Investments

Is South Africa uniquely set up for socially responsible investing?

Novo Nordisk and Eli Lilly’s GLP-1’s investment case just became even more compelling

The investment case for Novo Nordisk and Eli Lilly became even more compelling last week after a study found that the fast-selling weight loss GLP-1 drug semaglutide, sold as Ozempic and Wegovy, helps protect the kidney function of overweight or heart disease patients.

Riding out the rollercoaster of investor emotions

How self-help entered the SA equity debate

The best way to improve portfolio exposure to South African shares is to choose companies with a self-help ideology. In practice, this means finding those companies whose goods and services are so in demand locally that they can literally price their way out of trouble.